Freedland Cory S. 4
4 · Neurogene Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Freedland Cory S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-14+7,700→ 7,700 totalExercise: $42.59Exp: 2034-06-14→ Common Stock (7,700 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date.